A detailed history of Captrust Financial Advisors transactions in Globus Medical Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 20,520 shares of GMED stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,520
Previous 24,201 15.21%
Holding current value
$1.7 Million
Previous $1.66 Million 11.41%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.08 - $73.92 $246,921 - $272,099
-3,681 Reduced 15.21%
20,520 $1.47 Million
Q2 2024

Aug 14, 2024

BUY
$49.79 - $68.85 $61,291 - $84,754
1,231 Added 5.36%
24,201 $1.66 Million
Q1 2024

May 15, 2024

BUY
$51.15 - $56.52 $144,805 - $160,008
2,831 Added 14.06%
22,970 $1.23 Million
Q4 2023

Feb 14, 2024

SELL
$43.79 - $55.14 $577,414 - $727,076
-13,186 Reduced 39.57%
20,139 $1.07 Million
Q3 2023

Nov 14, 2023

BUY
$49.1 - $62.37 $269,706 - $342,598
5,493 Added 19.74%
33,325 $1.65 Million
Q2 2023

Aug 14, 2023

SELL
$52.61 - $59.54 $4,103 - $4,644
-78 Reduced 0.28%
27,832 $1.66 Million
Q1 2023

May 15, 2023

SELL
$51.83 - $79.63 $4,664 - $7,166
-90 Reduced 0.32%
27,910 $1.58 Million
Q4 2022

Feb 15, 2023

SELL
$58.4 - $75.53 $45,318 - $58,611
-776 Reduced 2.7%
28,000 $2.08 Million
Q3 2022

Nov 16, 2022

BUY
$55.32 - $67.54 $12,557 - $15,331
227 Added 0.8%
28,776 $1.71 Million
Q2 2022

Aug 23, 2022

SELL
$53.08 - $81.37 $35,457 - $54,355
-668 Reduced 2.29%
28,549 $1.6 Million
Q2 2022

Aug 16, 2022

BUY
$53.08 - $81.37 $39,385 - $60,376
742 Added 2.61%
29,217 $1.64 Million
Q1 2022

May 16, 2022

SELL
$63.68 - $75.54 $87,942 - $104,320
-1,381 Reduced 4.63%
28,475 $2.1 Million
Q4 2021

Feb 14, 2022

BUY
$62.62 - $79.92 $2,254 - $2,877
36 Added 0.12%
29,856 $2.16 Million
Q3 2021

Nov 16, 2021

BUY
$76.41 - $84.06 $23,305 - $25,638
305 Added 1.03%
29,820 $2.29 Million
Q2 2021

Aug 16, 2021

SELL
$61.85 - $77.53 $42,490 - $53,263
-687 Reduced 2.27%
29,515 $2.29 Million
Q1 2021

May 17, 2021

BUY
$60.05 - $67.74 $161,774 - $182,491
2,694 Added 9.79%
30,202 $1.86 Million
Q4 2020

Feb 16, 2021

SELL
$48.89 - $65.87 $391,315 - $527,223
-8,004 Reduced 22.54%
27,508 $1.79 Million
Q3 2020

Nov 17, 2020

BUY
$45.26 - $57.82 $55,126 - $70,424
1,218 Added 3.55%
35,512 $1.74 Million
Q2 2020

Aug 14, 2020

BUY
$39.81 - $55.61 $845,166 - $1.18 Million
21,230 Added 162.51%
34,294 $1.67 Million
Q1 2020

May 15, 2020

BUY
$35.06 - $59.45 $205,942 - $349,209
5,874 Added 81.7%
13,064 $522,000
Q4 2019

Feb 14, 2020

BUY
$49.45 - $59.5 $355,545 - $427,805
7,190 New
7,190 $427,000
Q2 2018

Aug 13, 2018

SELL
$47.96 - $57.41 $2,877 - $3,444
-60 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$42.75 - $51.73 $2,565 - $3,103
60 New
60 $3,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.37B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.